Healthcare

AVITA Medical Secures FDA Approval for RECELL GO® Mini, Expanding Tr...

Highlights:,FDA Approval:,RECELL GO Mini, designed for smaller wounds, enhances the functionality of the RECELL GO platform.,Optimized Design:,The car...

Avita Medical's Spray-On Skin Device Earns FDA Approval

Highlights,- Avita Medical (AVH) receives FDA approval for RECELL GO Mini, expanding its advanced wound care solutions.,- The new Mini GO device targe...

Imugene Secures Major Capital Boost to Advance Clinical Trials

Highlights,- Imugene extends cash runway to late 2025 through strategic capital injection.,- Funding supports clinical trials for key programs, includ...

Polynovo's Record Sales Drive ASX Momentum Amid Market Recovery

Highlights:,Polynovo,(PNV) surged on record-breaking monthly sales.,ASX recovered from last week’s technical disruptions to open on time.,Real Estate,...

PolyNovo Achieves Record $10.1M Monthly Sales in November 2024

Highlights,Record Monthly Sales:,PolyNovo reported,$10.1M,in unaudited sales for November 2024, marking the company's highest monthly performance to d...

Rhythm Biosciences Acquires Genetype Business from Genetic Technolog...

Highlights,Strategic Acquisition:,Rhythm Biosciences has entered into an Asset Sale Agreement (ASA) with the administrators of Genetic Technologies Lt...

Prescient Therapeutics Shares Surge 24% on FDA Approval for PTX-100...

Highlights,FDA Clears Phase 2 IND:,The U.S. FDA has approved Prescient Therapeutics' Investigational New Drug (IND) application for its Ras pathway in...

Pro Medicus Shares Rise Following AU$30 Million Contract with Duly H...

Highlights,AU$30 Million Contract Signed:,Pro Medicus secures a seven-year deal with Duly Health and Care, the largest physician-directed medical grou...

FDA Clears Prescient Therapeutics (ASX:PTX) for Phase 2 PTX-100 Tria...

Highlights,Prescient Therapeutics (PTX) receives FDA clearance for a Phase 2 trial of PTX-100.,The trial focuses on relapsed and refractory cutaneous...

Pro Medicus Expands U.S. Presence with $30m Deal

Highlights,Pro Medicus (PME) secures a long-term partnership with Duly Health and Care.,The $30m agreement focuses on implementing advanced cloud imag...

Integral Diagnostics Completes Merger with Capitol Health, Appoints...

Highlights,Merger Completion:,Integral Diagnostics (ASX: IDX) has completed its merger with Capitol Health (ASX: CAJ) through a scheme of arrangement....

Little Green Pharma to Acquire Health House Australia for AU$1.25Mn

Highlights,Strategic Acquisition:,Little Green Pharma signs a binding letter of intent to acquire Health House Australia Pty Ltd for $1.25 million.,Re...

Radiopharm Theranostics Advances with Phase 1 Cancer Trial Approval

Highlights,Radiopharm,Theranostics,(RAD) secures ethics approval for a Phase 1 cancer trial,.,The trial targets HER2-positive cancers using the novel...

Radiopharm Theranostics Receives Approval for Lu-RAD202 Clinical Tri...

Highlights,Radiopharm Theranostics Ltd (ASX:RAD) has gained ethics approval to commence Phase 1 trials for Lu-RAD202, a candidate treatment for HER2-p...

Mesoblast (ASX:MSB) Gains Momentum with FDA Approval for Ryoncil The...

Highlights,FDA approval boosts Mesoblast (MSB) with new therapy Ryoncil.,Ryoncil marks the first approved therapy for SR-aGvHD in the US.,Mesoblast se...

Mesoblast's (ASX:MSB) Ryoncil Secures Historic FDA Approval for SR-a...

Highlights,Ryoncil,becomes the first FDA-approved mesenchymal stromal cell therapy for SR-,aGvHD,.,Mesoblast (,ASX:MSB,) expands treatment options for...

Breakthrough: Mesoblast (ASX:MSB) Gains FDA Approval for First MSC T...

Highlights,Mesoblast (MSB) secures FDA approval for RYONCIL®,.,RYONCIL,becomes,the first mesenchymal stromal cell therapy approved in the US,.,Signifi...

Austco Healthcare Limited (ASX:AHC): Examining Performance Metrics A...

Highlights:,Austco Healthcare Limited (,ASX:AHC,) has a price-to-earnings (P/E) ratio of 13.9x, significantly lower than the broader Australian market...

LTR Pharma Partners with Men’s Health Downunder for Erectile Dysfunc...

Highlights,LTR Pharma partners with MHDU to introduce SPONTAN, a nasal spray for erectile dysfunction.,Collaboration provides access to MHDU’s extensi...

Mesoblast Shares Surge 33% as FDA Approves Groundbreaking RYONCIL® T...

Highlights,FDA approves Mesoblast’s RYONCIL® (remestemcel-L), the first mesenchymal stromal cell (MSC) therapy in the U.S.,RYONCIL becomes the only ap...